Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-01 10:46 am Sale | 2022-12-31 | 13G | Dynavax Technologies Corporation DVAX | FEDERATED HERMES INC. FHI | 12,640,363 9.910% | -4,142,475 (-24.68%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Dynavax Technologies Corporation DVAX | BlackRock Inc. BLK | 19,086,463 15.000% | 0 (Unchanged) | Filing History |
| 2023-01-20 3:00 pm Purchase | 2022-12-31 | 13G | Dynavax Technologies Corporation DVAX | BlackRock Inc. BLK | 19,086,463 15.000% | 1,778,741 (+10.28%) | Filing History |
| 2022-08-17 5:00 pm Sale | 2022-08-15 | 13D | Dynavax Technologies Corporation DVAX | Bain Capital Life Sciences Fund, L.P. | 4,912,610 3.900% | -2,721,435 (-35.65%) | Filing History |
| 2022-06-09 3:20 pm Purchase | 2022-05-31 | 13G | Dynavax Technologies Corporation DVAX | BlackRock Inc. BLK | 17,307,722 13.700% | 9,439,398 (+119.97%) | Filing History |
| 2022-03-04 4:02 pm Sale | 2021-12-31 | 13G | Dynavax Technologies Corporation DVAX | Chicago Capital LLC | 5,734,000 4.700% | -127,272,000 (-95.69%) | Filing History |
| 2022-03-04 2:18 pm Purchase | 2021-12-31 | 13G | Dynavax Technologies Corporation DVAX | Chicago Capital LLC | 133,006,000 4.300% | 128,778,237 (+3046.01%) | Filing History |
| 2022-02-14 1:17 pm Purchase | 2021-12-31 | 13G | Dynavax Technologies Corporation DVAX | FEDERATED HERMES INC. FHI | 16,782,838 13.920% | 4,261,038 (+34.03%) | Filing History |
| 2022-02-11 07:54 am Purchase | 2021-12-31 | 13G | Dynavax Technologies Corporation DVAX | STATE STREET CORP STT | 6,245,356 5.210% | 1,031,099 (+19.77%) | Filing History |
| 2022-02-01 5:08 pm Sale | 2021-12-31 | 13G | Dynavax Technologies Corporation DVAX | BlackRock Inc. BLK | 7,868,324 6.600% | -319,832 (-3.91%) | Filing History |
| 2021-10-12 12:14 pm Sale | 2021-09-30 | 13G | Dynavax Technologies Corporation DVAX | STATE STREET CORP STT | 5,214,257 4.540% | -5,673,039 (-52.11%) | Filing History |
| 2021-08-27 5:17 pm Sale | 2021-08-27 | 13D | Dynavax Technologies Corporation DVAX | Bain Capital Life Sciences Fund, L.P. | 7,634,045 6.400% | -2,780,955 (-26.70%) | Filing History |
| 2021-08-11 5:16 pm Sale | 2021-08-09 | 13D | Dynavax Technologies Corporation DVAX | Bain Capital Life Sciences Fund, L.P. | 10,415,000 13.000% | -1,356,708 (-11.53%) | Filing History |
| 2021-06-11 5:16 pm Purchase | 2021-06-10 | 13D | Dynavax Technologies Corporation DVAX | Bain Capital Life Sciences Fund, L.P. | 11,771,708 13.000% | 875,935 (+8.04%) | Filing History |